We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Continues Communications Staff Upheaval in Wake of Convalescent Plasma Bungle
FDA Continues Communications Staff Upheaval in Wake of Convalescent Plasma Bungle
The FDA has ousted another high-ranking communications officer following fallout from FDA Commissioner Stephen Hahn’s misrepresentation of convalescent plasma as a COVID-19 treatment.